← Leaderboards
Nels C. Olson
University Of Vermont & St Agric College
$1,002,920
Attributed
$1,038,155
Total exposure
6
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $805.2K · FY2016–25$1M$750K$500K$250K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,570,704 · 7
By mechanism
U01$1,603,020 · 5
R00$744,660 · 1
K99$223,024 · 1
Top collaborators
- Laura M Raffield6 shared
Most similar at University Of Vermont & St Agric College
Same institution · by research overlap
- Neil Adrian Zakai$5,929,736
- Katharine L. Cheung$1,060,966
- Mark T Nelson$29,623,993
- Debora Kamin Mukaz$128,752
Others in their field
Top investigators on “Phenotype”
- David R. Weir · University Of Michigan At Ann Arbor$239,033,262
- David Heimbrook · Leidos Biomedical Research, Inc.$213,586,034
- Constance Ann Benson · University Of California, San Diego$187,132,366
- Richard A Gibbs · Baylor College Of Medicine$184,906,270
- James E. Gern · University Of Wisconsin-Madison$141,704,104
- Garret A Fitzgerald · University Of Pennsylvania$141,348,491
Research focus
PhenotypeAdultFollow-UpRisk FactorsInflammationBiological MarkersCardiovascular SystemC-Reactive ProteinParticipantPlasmaPathologyInflammatoryCohort StudiesChronicBehavioralAntibodiesBiometryAncillary StudyBasic ScienceBiochemical GeneticsBiostatistical MethodsAwardBaseAutoantibodies
Grant awards (11)
Proteomic biomarkers of incident cognitive impairment in Black and White adults$727,319
U01 · FY2025 · AG
ConProject-001$47,541
U01 · FY2025 · AG
ConProject-002$9,249
U01 · FY2025 · AG
ConProject-004$8,775
U01 · FY2025 · AG
ConProject-003$4,906
U01 · FY2025 · AG
Proteomic biomarkers of incident cognitive impairment in Black and White adults$805,230
U01 · FY2024 · AG
Immune Activation and Immunosenescence Biomarkers and Cardiovascular Disease Risk$247,274
R00 · FY2020 · HL · contact PI
Immune Activation and Immunosenescence Biomarkers and Cardiovascular Disease Risk$248,441
R00 · FY2019 · HL · contact PI
Immune Activation and Immunosenescence Biomarkers and Cardiovascular Disease Risk$248,945
R00 · FY2018 · HL · contact PI
Immune Activation and Immunosenescence Biomarkers and Cardiovascular Disease Risk$111,512
K99 · FY2017 · HL · contact PI
Immune Activation and Immunosenescence Biomarkers and Cardiovascular Disease Risk$111,512
K99 · FY2016 · HL · contact PI